Surgical versus non-surgical treatment for carpal tunnel syndrome
Author
dc.contributor.author
Verdugo Latorre, Renato
Author
dc.contributor.author
Salinas, Rodrigo
Author
dc.contributor.author
Castillo, José
Author
dc.contributor.author
Cea, José
Admission date
dc.date.accessioned
2018-12-20T15:24:41Z
Available date
dc.date.available
2018-12-20T15:24:41Z
Publication date
dc.date.issued
2008
Cita de ítem
dc.identifier.citation
Surgical versus non-surgical treatment for carpal tunnel syndrome (Review), 2008, Issue 4, 2008, Pages 1-23.
Identifier
dc.identifier.issn
1469493X
Identifier
dc.identifier.other
10.1002/14651858.CD001552.pub2
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/159055
Abstract
dc.description.abstract
Background
Carpal tunnel syndrome results from entrapment of the median nerve in the wrist. Common symptoms are tingling, numbness, and
pain in the hand that may radiate to the forearm or shoulder. Most symptomatic cases are treated non-surgically.
Objectives
The objective is to compare the efficacy of surgical treatment of carpal tunnel syndrome with non-surgical treatment.
Search strategy
We searched the Cochrane Neuromuscular Disease Group Trials Register (January 2008), MEDLINE (January 1966 to January 2008),
EMBASE (January 1980 to January 2008) and LILACS (January 1982 to January 2008). We checked bibliographies in papers and
contacted authors for information about other published or unpublished studies.
Selection criteria
We included all randomised and quasi-randomised controlled trials comparing any surgical and any non-surgical therapies.
Data collection and analysis
Two authors independently assessed the eligibility of the trials.
Main results
In this update we found four randomised controlled trials involving 317 participants in total. Three of them including 295 participants,
148 allocated to surgery and 147 to non-surgical treatment reported information on our primary outcome (improvement at three
months of follow-up). The pooled estimate favoured surgery (RR 1.23, 95% CI 1.04 to 1.46). Two trials including 245 participants
described outcome at six month follow-up, also favouring surgery (RR 1.19, 95% CI 1.02 to 1.39).
Two trials reported clinical improvement at one year follow-up. They included 198 patients favouring surgery (RR 1.27, 95% CI 1.05
to 1.53). The only trial describing changes in neurophysiological parameters in both groups also favoured surgery (RR 1.44, 95% CI
1.05 to 1.97). Two trials described need for surgery during follow-up, including 198 patients. The pooled estimate for this outcome indicates that a significant proportion of people treated medically will require surgery while the risk of re-operation in surgically treated
people is low (RR 0.04 favouring surgery, 95% CI 0.01 to 0.17). Complications of surgery and medical treatment were described
by two trials with 226 participants. Although the incidence of complications was high in both groups, they were significantly more
common in the surgical arm (RR 1.38, 95% CI 1.08 to 1.76).